-
Mashup Score: 4
“Sibling” of original may extend Omicron surges but no evidence yet it causes more severe disease
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3After Omicron, some scientists foresee ‘a period of quiet’ - 2 year(s) ago
The variant’s modest toll in many countries has led to a sense of optimism. But new surprises are likely
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 4
A mutated version of the Omicron variant could slow the steep decline in cases, but it is not likely to change the overall course of the pandemic, scientists said.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2After Omicron, some scientists foresee ‘a period of quiet’ - 2 year(s) ago
The variant’s modest toll in many countries has led to a sense of optimism. But new surprises are likely
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The FDA cited monoclonal antibodies as being less effective against the Omicron variant in their decision to rescind their earlier approval of the COVID-19 treatment.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 18After Omicron, some scientists foresee ‘a period of quiet’ - 2 year(s) ago
The variant’s modest toll in many countries has led to a sense of optimism. But new surprises are likely
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 10Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) - 2 year(s) ago
Introduction Early reports showed that Omicron (BA.1) SARS-CoV-2 could be less severe. However, the magnitude of risk reduction of hospitalization and mortality of Omicron (BA.1) infections compared with Delta (B.1.617.2) is not yet clear. This study compares the risk of severe disease among patients infected with the Omicron (BA.1) variant with patients infected with Delta (B.1.617.2) variant in…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
#COVID19 lessons from Portugal: Compared to #Delta, the #OmicronVariant results in 75% lower hospitalizations. Vaccinations that include boosters reduce hospitalizations by >90% @VincentRK @NarjustDumaMD @ZiadBakouny @DrLindaMD @NancyLapid @JacqEHoward https://t.co/jWFmtzmeIv https://t.co/5FWDe5x4OG
-
-
Mashup Score: 95Effectiveness of a Third Dose of mRNA Vaccines ... - 2 year(s) ago
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 50COVID Data Tracker - 2 year(s) ago
CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 9Study identifies mutations specific to omicron variant - 2 year(s) ago
While the omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the omicron variant’s high rate of infection.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
Scientists are now trying to make sense of why BA.2, a related strain of the #OmicronVariant, is exploding and what its emergence means. https://t.co/W1Bx0JGlv5